Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advaxis receives patent in Japan for ADXS-HPV for treatment of cervical cancer
The claims of the patent (patent number 5479918) cover the use of ADXS-HPV for the treatment of late-stage cervical cancer with a term that extends to 2028. Advaxis
The claims of the patent (patent number 5479918) cover the use of ADXS-HPV for the treatment of late-stage cervical cancer with a term that extends to 2028. Advaxis
EDGE is the trading and registration platform used by exchanges, brokerage firms and banks in multiple markets throughout the world. Oslo Connect combines the flexibility of the OTC
Trellis’ discovery platform, called CellSpot, uses computerized microscopy to drastically miniaturize a multiplexed antigen binding assay capable of characterizing millions of individual antibody producing B cells. Hence, CellSpot
The strategic collaboration is designed to support the commercial development of Generx and Excellagen by Taxus Cardium, and also to provide new opportunities to explore the commercialization of
Drs Kratz and Warnecke and their scientific team will expand the Corporation’s novel albumin-binding anti-cancer drug pipeline. Dr Kratz, one of the most highly regarded conjugation chemists in
The company plans to conduct the Phase II study in Israel, Europe and the US and it will include 78 subjects that will be dosed with the drug
Data generated from this agreement will demonstrate the combination of the unique Advaxis immunotherapy platform, which generates both tumor fighting T cells and reduces tumor protection inside the
The particulate matter was found in a small number of vials in the three packaged lots of VPRIV. A Shire investigation identified the particulate matter root cause as
Pfizer Global Innovative Pharmaceuticals Business Medicines Development Group head and senior vice president Dr Steven J Romano noted as the number of hip and knee replacement surgeries performed
SmartFactory is a single-use cGMP bio-manufacturing capacity, which will allow Alvotech to rapidly expand its biosimilars business. Finesse’s customers will benefit from unprecedented access to Alvogen’s commercial, the